A randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: The LARCID trial.
Paulo Marcelo Hoff
Research Funding - Novartis
Daniel Fernandes Saragiotto
No relevant relationships to disclose
Carlos H. Barrios
No relevant relationships to disclose
Auro Del Giglio
No relevant relationships to disclose
Anelisa Kruschewsky Coutinho
No relevant relationships to disclose
Aline C Andrade
No relevant relationships to disclose
Carolina Dutra
No relevant relationships to disclose
Nora Forones
No relevant relationships to disclose
Mariangela Correa
No relevant relationships to disclose
Maria Socorro Portella
Employment or Leadership Position - Novartis
Vanessa Q. Passos
Employment or Leadership Position - Novartis
Renata N Chinen
Employment or Leadership Position - Novartis
Brigitte van Eyll
No relevant relationships to disclose